222. Primary nephrotic syndrome Clinical trials / Disease details


Clinical trials : 285 Drugs : 285 - (DrugBank : 108) / Drug target genes : 62 - Drug target pathways : 191

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00193648
(ClinicalTrials.gov)
July 200510/9/2005Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)Novel Therapies for Resistant FSGSFocal GlomerulosclerosisDrug: Rosiglitazone (Avandia);Drug: Adalimumab (Humira)North Shore Long Island Jewish Health SystemUniversity of North Carolina;The Cleveland ClinicCompleted2 Years40 YearsBoth21Phase 1United States